L ittLe has been done in the analysis of weight gain or loss in patients with neuropathic pain. The studies addressing body weight or patient appetite in relation to pain have been self-report studies. Studies of postoperative pain markers in children have found that parents reliably report a loss of appetite in their children. 10 Postoperatively, parents have reported that their children refuse to eat or eat less than usual when in pain.
L ittLe has been done in the analysis of weight gain or loss in patients with neuropathic pain. The studies addressing body weight or patient appetite in relation to pain have been self-report studies. Studies of postoperative pain markers in children have found that parents reliably report a loss of appetite in their children. 10 Postoperatively, parents have reported that their children refuse to eat or eat less than usual when in pain. 2 Results from these studies suggest that acute pain is associated with behaviors that could lead to weight loss. However, the data on chronic pain presents a different picture. Attempts at assessing weight loss in the patient population with chronic pain have only been indirect through the assessment of self-report scales for depression. Two studies found no statistically significant difference between patients with chronic pain and those who are pain free in their self-reports of weight loss. 8, 12 These self-report studies indicate that acute and chronic pain act differently on patient body weight; acute pain is associated with weight loss, and chronic pain does not affect body weight and has not been reported to cause overall weight gain or loss.
Studies of pain in animal models present a different picture. In a rat model of postoperative pain, weight loss was mitigated by effective analgesia, implicating acute pain in weight loss, similar to the human studies.
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Several rat models of chronic, neuropathic pain have demonstrated weight loss concurrent with the development of neuropathic pain signs. 1, 3, 4 These studies suggest that experimental chronic pain is associated with weight loss, contrary to the results from the human self-reports above. Given the influence of postoperative pain on body weight, an effective analysis of the impact of chronic pain on body weight would require a comparison sham-operated group since all chronic pain models are produced by surgical intervention, which confounds the chronic performed such a comparison, demonstrating that rats with cut sciatic nerves, the neuroma model of chronic pain, had greater weight loss than rats having sham surgery. These rats did not catch up to the sham-operated rats in weight over several weeks. However, the authors of that paper discuss how poor the neuroma model is as a model for pain. It is unclear how many of the rats actually developed chronic pain. The evidence for chronic pain in this model is autotomy of the affected limb, which could also be a reaction to new sensation of the limb or lack of sensation in the limb.
In this study, we used a more reliable model of neuropathic pain in the rat 1 in comparison with sham-operated and unoperated rats to determine the impact of chronic neuropathic pain and acute postoperative pain on body weight. Our hypothesis, based on the animal studies which were more objective than the human studies, was that neuropathic pain would have a greater and longerlasting effect on reducing body weight than acute postoperative pain in this model. This would be an important finding in developing a nutrition approach to patients with neuropathic pain. Appropriate nutritional support would be important given the impact of malnutrition on overall health and on surgical results 6 in a population that may require surgical intervention for chronic pain.
Methods
This study was approved by the animal care and use committee at the George Washington University. One hundred eighteen male Sprague-Dawley rats (Harlan) weighing 250-300 g were weighed for a baseline value and separated into the following 3 groups: common sciatic nerve ligation surgery, sham surgery without nerve ligation, and no surgery. The rats undergoing surgery were given 1 mg/kg atropine subcutaneously and anesthetized with 55 mg/kg sodium pentobarbital intraperitoneally. In 45 rats the common sciatic nerve was exposed at the level of the middle thigh by blunt dissection through the biceps femoris. Four loose ligatures of 4-0 chromic gut suture were tied around the nerve in 1-mm intervals as per the protocol of Bennett and Xie. 1 The ligatures were tied to constrict the surface of the nerve as seen under a magnification of 40. The incision was then closed with 4-0 nylon sutures using interrupted vertical mattress stitches. Fortytwo male Sprague-Dawley rats underwent the same surgical procedure including exposure of the common sciatic nerve, but no ligatures were tied around the sciatic nerve. A third group of 40 rats received no surgery.
The rats were further randomly divided into 3 roughly equal groups representing different durations of the experiment. At 3, 7, or 14 days after the surgery depending on the study group each rat was weighed and tested for signs of pressure and heat hyperalgesia. In the pressure hyperalgesia test, the pressure (in grams) at which limb withdrawal occurred was recorded. Four measurements were taken at 3-minute intervals such that each paw was tested every 6 minutes. These 4 measurements were then averaged. In the heat hyperalgesia test, the plantar surface of the hind paw was heated by a radiant heat source as the rat stood on a clear glass plate. The duration from heat onset to paw withdrawal (in seconds) was recorded. Four measurements were taken at 3-minute intervals such that each paw was tested every 6 minutes, and the 4 measurements were averaged.
Results
The rats that underwent ligation surgery demonstrated neuropathic pain signs on the paw pinch test (Fig. 1 , F = 14.3, p < 0.0001) and on the paw heat test (Fig. 2 , F = 34.8, p < 0.0001), whereas the nonligation surgery and unoperated rats did not. The effect on the percentage of change in body weight was statistically significant for surgical condition (Fig. 3, F = 15 .0, p < 0.0001) and day of testing (F = 43.3, p < 0.0001). The nonligation surgery group, while exhibiting initial weight loss, gained weight by Day 14 similar to the control group. In the ligation surgery group the change was −6.3% on Day 3, −0.7% on Day 7, and 4.9% on Day 14. This group initially lost more weight than the postoperative pain group. These rats began gaining weight by Day 14 but still lagged behind the other 2 groups. At the end of the study, the animals were anesthetized with sodium pentobarbital intraperitoneally and perfused intracardially with ice-cold 4% paraformaldehyde solution.
Discussion
In this study, pain had a significant impact on weight gain, whether acute or chronic. Whereas unoperated rats had a steady increase in body weight at 3, 7, and 14 days, rats with postoperative pain and those with neuropathic pain initially had a loss of body weight. Given the relatively short duration of the surgeries (10-20 minutes) and the insignificant blood loss, these differences would not be explained by postoperative fluid shifts. Rather, they seem to represent the impact of pain on caloric intake and subsequent body growth. At later time points when one would expect the incisional pain to have resolved, the nonligation surgery animals had an accelerated weight gain and eventually had a similar overall weight gain from baseline by Day 14 as the unoperated rats. In contrast, the rats with persistent neuropathic pain eventually started increasing their weight, but never reached the level of weight gain from baseline as their unoperated counterparts within the 14-day study period. This would suggest that the pain, and the persistence or resolution of the pain, impacts the animals' ability to maintain normal growth patterns.
Pain is known to have a significant impact on a patient's physiology and psychology. A great deal of study has gone into the impact of postoperative pain on appetite and weight gain because this can influence wound healing and operative success. 6 One study showed that the alleviation of pain with analgesics after laparotomy increased rat weight gain in the postoperative period, 11 suggesting a role of postoperative pain in the inhibition of weight gain. The effects of postoperative pain on weight loss are thought to occur through ileus 5 and appetite suppression produced by inflammatory mediators.
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Although chronic neuropathic pain lasts longer than acute pain and can have a greater overall impact on an individual, the influence of chronic neuropathic pain on appetite and weight gain has not been well characterized in animal studies, and it remains unaddressed in objective clinical studies. Investigators have made the reverse comparison, demonstrating that obesity can increase the incidence and severity of chronic pain. 7 In an analysis of self-report measures of depression, patient reports of weight loss were no different in the chronic pain population compared with pain-free patients. 8, 12 A neuroma pain model in the rat inhibited weight gain compared with sham surgery; 3 however, there were potential confounds of this pain model because of its effects on overall rat behaviors (autotomy and decreased activity). The authors of that paper found no correlation between 3 proposed indirect measures of pain in these animals: autotomy, activity level, and body weight. Because this model produces anesthesia in the limb, the investigators could not perform direct tests of pain, such as the pressure and thermal hyperalgesia tests used in the current study. They concluded that they could not definitively assert that any or all of the rats truly developed neuropathic pain.
In the current study, we were able to provide objective signs of neuropathic pain in the animals, including pressure and heat hyperalgesia, to verify that we were assessing true chronic, neuropathic pain. Similar to the current study, the neuroma study showed that the rats with chronic pain eventually started to gain weight but never reached similar weight gain as the sham surgery animals. 3 Both the neuropathic pain rats and the sham-operated rats in the current study lost weight postoperatively compared with the unoperated rats that continued to gain weight consistent with their expected growth. However, by Day 14 the sham-operated rats had achieved similar weight gain to the unoperated rats, but the chronic, neuropathic pain rats remained at a lower weight than the other 2 groups.
Conclusions
These findings suggest that chronic neuropathic pain has a chronic impact on weight gain and body growth, which outlasts that of postoperative acute pain. This could potentially have a long-term effect on overall health. Effective treatment of chronic pain may have a significant impact on many areas of a patient's health, and monitoring patient weight loss or gain may potentially be an objective method for evaluating efficacy of chronic pain treatment. These findings should be further investigated in human studies to determine the clinical relevance in patients with chronic pain. Both the neuropathic pain model and sham surgery rats showed early weight loss. However, by Day 14, the sham surgery rats had caught up to the unoperated rats in comparative weight gain, whereas the neuropathic pain model rats had not.
